Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTGYB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,253
Award facts
- Contract value 100% obligated
- $25,253.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,253.12 for Gardasil 9 syringes (0.5ml) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Gardasil 9 is a recombinant human papillomavirus vaccine used to prevent HPV-related cancers and diseases, making this procurement part of the Defense Health Agency's pharmaceutical supply chain supporting military healthcare programs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal contract portfolio predominantly with the Defense Logistics Agency and has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DB25FTGYB?
SPE2DB25FTGYB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FTGYB worth?
The government has obligated $25,253 on SPE2DB25FTGYB.
Is contract SPE2DB25FTGYB an order under another contract?
Yes. SPE2DB25FTGYB is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGYB competed?
The extent of competition for SPE2DB25FTGYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award